Novogene Co., Ltd. (SHSE: 688315)
Health Care · Life Sciences Tools & Services · CN
CN¥15.95
-1.54% today · -3.3% 1Y
Novogene Co., Ltd. (SHSE: 688315) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $961.07M and employs 2,225 people.
Over the last twelve months the share price has lost 3.3%, trading between 11.46 and 18.24.
Tweenvest scores Novogene Co., Ltd. across four factors: quality 72/100, value 51/100, growth 18/100, dividend 7/100. Its strongest factor is quality.
688315 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $961.07M
- Revenue (TTM)
- $328.25M
- P/E
- 39.89
- EPS
- 0.40
- Dividend yield
- 0.28%
- Beta (5Y)
- 0.71
- 52-week high
- CN¥18.24
- 52-week low
- CN¥11.46
- Avg volume (3M)
- —
- Shares outstanding
- 405.06M
- Employees
- 2,225
- Next earnings
- —
About Novogene Co., Ltd.
Novogene Co., Ltd. is a global provider of comprehensive genomic services and advanced solutions. Its offerings span a wide array of genomic applications, including human, animal, plant, and microbial genome sequencing, alongside gene regulation and single-cell sequencing technologies. The company also specializes in cancer genomic profiling, whole exome sequencing (including clinical-grade versions), and FFPE RNA sequencing. Furthermore, Novogene develops proprietary tools such as NovoFocus, a next-generation sequencing (NGS)-based companion diagnostic for PARP inhibitor treatments, and NovoNeoantigen, a bioinformatics pipeline that identifies cancer neoantigens by analyzing whole exome and whole transcriptome sequencing data from matched tumor and normal samples. In a strategic collaboration, Novogene partners with Hummingbird Bioscience Pte. Ltd. to aid in the advancement of HMBD-001. This investigational anti-HER3 antibody is being assessed for its potential to treat diverse cancer types, notably those driven by NRG1-fusion. Established in 2011, Novogene Co., Ltd. operates from its headquarters in Beijing, China.
- ISIN
- CNE1000052X3
- Founded
- 2011
- Listed since
- Apr 13, 2021
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Thermo Fisher Scientific Inc.NYSE: TMO | $232.67B | $629.27 | +0.27% |
| Danaher CorporationNYSE: DHR | $153.85B | $218.85 | +1.36% |
| WuXi AppTec Co., Ltd.SHSE: 603259 | $72.12B | CN¥162.86 | -3.00% |
| Samsung Biologics Co.,Ltd.KOSE: A207940 | $51.75B | ₩1,551,000.00 | +0.19% |
| Lonza Group AGSWX: LONN | $51.61B | CHF588.60 | -0.61% |
| Agilent Technologies, Inc.NYSE: A | $44.91B | $159.00 | +1.73% |
| IQVIA Holdings Inc.NYSE: IQV | $42.77B | $259.82 | +1.47% |
| Waters CorporationNYSE: WAT | $40.35B | $410.70 | +1.49% |
Figures last refreshed Aug 18, 2026.